Xu et al. [69] developed an estrone-targeted liposomal system to deliver mitoxantrone in human acute myeloblastic leukemia treatment, and the in vivo experiment conducted in mouse showed that the liposomal nano-DDS could be well delivered to targeted ER-expressing tumor cells. This evidence concerns the gene ESR1 and acute myeloid leukemia.